Literature DB >> 8101257

Spectrum of immunodeficiency in HIV-1-infected patients with pulmonary tuberculosis in Zaire.

Y Mukadi1, J H Perriëns, M E St Louis, C Brown, J Prignot, J C Willame, F Pouthier, M Kaboto, R W Ryder, F Portaels.   

Abstract

Tuberculosis (TB) is the most common opportunistic infection in African patients who die from AIDS, yet the stage of immunodeficiency at which TB develops is uncertain. We studied the immune status of HIV-infected outpatients with pulmonary TB in relation to their clinical presentation in a cross-sectional study of 216 HIV-seropositive and 146 HIV-seronegative ambulatory incident cases of smear-positive and culture-positive pulmonary TB in Kinshasa, Zaire. HIV-seropositive and seronegative patients had median CD4 lymphocyte counts of 316.5/microL and 830.5/microL, respectively. Of the HIV-seropositive patients, 32.9% had less than 200 CD4 lymphocytes/microL, 37% between 200 and 499, and 30.1% 500 or more. Clinical AIDS, as defined by the WHO clinical case-definition or a modified version, was of similar limited use as a predictor of immunodeficiency. Among HIV-seropositive patients, oral candidosis, lymphopenia, a negative tuberculin purified protein derivative test, and cutaneous anergy were strongly associated with CD4 counts of less than 200/microL, and seemed to be better markers of immune dysfunction. We conclude that pulmonary TB develops across a broad spectrum of HIV-induced immunodeficiency and that a diagnosis of pulmonary TB is of limited use as a marker of stage of HIV disease in African HIV-infected outpatients.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Case Control Studies; Clinical Research; Cross Sectional Analysis; Developing Countries; Diseases; Examinations And Diagnoses; French Speaking Africa; Hiv Infections; Immunity; Immunological Effects; Infections; Middle Africa; Physiology; Research Methodology; Screening; Studies; Tuberculosis; Viral Diseases; Zaire

Mesh:

Year:  1993        PMID: 8101257     DOI: 10.1016/0140-6736(93)91346-n

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  36 in total

1.  Efficacy of an unsupervised 8-month rifampicin-containing regimen for the treatment of pulmonary tuberculosis in HIV-infected adults. Uganda-Case Western Reserve University Research Collaboration.

Authors:  J L Johnson; A Okwera; P Nsubuga; J G Nakibali; C C Whalen; D Hom; M D Cave; Z H Yang; R D Mugerwa; J J Ellner
Journal:  Int J Tuberc Lung Dis       Date:  2000-11       Impact factor: 2.373

2.  Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Authors:  S D Lawn; A D Harries; B G Williams; R E Chaisson; E Losina; K M De Cock; R Wood
Journal:  Int J Tuberc Lung Dis       Date:  2011-05       Impact factor: 2.373

Review 3.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 4.  HIV: treating tuberculosis.

Authors:  Brendan Payne; Richard Bellamy
Journal:  BMJ Clin Evid       Date:  2009-11-05

Review 5.  Practical and affordable measures for the protection of health care workers from tuberculosis in low-income countries.

Authors:  A D Harries; D Maher; P Nunn
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

6.  Retinal findings in Malawian patients with AIDS.

Authors:  S Lewallen; J Kumwenda; D Maher; A D Harries
Journal:  Br J Ophthalmol       Date:  1994-10       Impact factor: 4.638

Review 7.  Tuberculosis and HIV disease: two decades of a dual epidemic.

Authors:  Muktar H Aliyu; Hamisu M Salihu
Journal:  Wien Klin Wochenschr       Date:  2003-10-31       Impact factor: 1.704

8.  Immune biology of macaque lymphocyte populations during mycobacterial infection.

Authors:  X Lai; Y Shen; D Zhou; P Sehgal; L Shen; M Simon; L Qiu; N L Letvin; Z W Chen
Journal:  Clin Exp Immunol       Date:  2003-08       Impact factor: 4.330

9.  Reactivation of latent tuberculosis in cynomolgus macaques infected with SIV is associated with early peripheral T cell depletion and not virus load.

Authors:  Collin R Diedrich; Joshua T Mattila; Edwin Klein; Chris Janssen; Jiayao Phuah; Timothy J Sturgeon; Ronald C Montelaro; Philana Ling Lin; Joanne L Flynn
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

10.  Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved.

Authors:  Iñaki Comas; Jaidip Chakravartti; Peter M Small; James Galagan; Stefan Niemann; Kristin Kremer; Joel D Ernst; Sebastien Gagneux
Journal:  Nat Genet       Date:  2010-05-23       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.